I've subscribed to the Daily Wealth for the last year. They are up 14% for the yr. They are a contrarian type and leave it up to you when to get in and out. They have 3 or 4 different levels up to $995/yr for their premium advice. You will receive a daily email with their outlook on the economy.

Thanks for the feedback, although with all the guaranteed easy money they predict, you would think they would be up more than 14% for the year. Definitely some good leads worth looking into, so I guess that's worth the subscription. I only have the $99, but I would be curious if anyone has paid the 1K for premium and if it has paid off.

hallo guyssssss!!!
I'm here to spend only good words for stansberry!!!
I've got many subscriptions...and every mounth I'm waiting for the new issues...
they are great guys...never found so accurate reports...even if sometimes they don't consider the bed aspects of a pick (icelands bonds 4 exemple!!!)
i've got the truewealth subscription, psia, oil report 12%letter, medical investor, pennyletter....and I don't remember the others...NO REGREAT!!!
if u need to uncover the names of company do not esitate!!!!ASK ME FOR IT!!!
but plse help me with the most expansive subscription they have...PHASE 1...don't waqnt to spend that amount of money... ;(((((
I know some of the company they cover in it (such as YMI, ARENA PHARMA, SANGAMO BIOSCIENCES, IDENIX pharma...) but I miss many others....

Subscribed to Stansberry about a month ago. They may have good tips, but my impresson so far is that it's mostly all ads for you to buy more services and reports. I would have spent quite a bit more money if I kept saying yes!

I've been sleuthing teaser emails since 1998 when I was getting teasers from taipan, flying v and a ton of others.. there's no need to pay expensive news letter fees, when you can sleuth them out yourself, and besides most of the picks aren't even worth investing.

I've had the $50 news letter up to the $5,000 ones

There's one news letter that's $50 a year I've had for 9 yrs so I've paid $450 and it was well worth it, that's why I keep renewing it year after year, they don't boast all this ridiculous bs about making 100 times your money over the next 12 months, but they do make prediction before mainstream catches on and most of their picks are over the long run.

I've paid the high price news letter just to see all their picks and follow them. I had the Stansberry all the S & A short report, oil, gold etc etc , it wasn't that great, sure they had big winners but its not like you put all your money on the big one because you don't know which one it will be so you end up put a little into every pick and you don't end up that much ahead. but they do refund money if you cancel.

The option hotline is the worst and so misleading they claim 1 or 2 losers out of their 52 option picks a year,, 50 is a winner, hahaha its more like everyone of their picks is a loser, I know for fact because I followed it for almost a year.

I would have to say the $50 dollar a year subscriptions is way better, it turned 100,000 into 368,000 in 9 yrs , so I average 30K a year, not too bad considering I had some considerable losses from options and bio techs recommends from other pricey NL, So this $50 a year news letter "outstanding investments" kept my portfolio afloat. I have how ever moved $40k over to small caps, and the rest is still invested with OSI picks. I was invested in natural resources over the last 9 years, way back when not too many people were talking about Gold, oil, and other N.R. but O.I. was recommending gold mining co. in the 90's when gold was under the radar still .

You don't need to buy expensive news letters to find good stocks, trust me, I wasted more then a few grand on news letters just to see what the other picks were, I didn't buy because of the teasers, the teaser are mostly easy to find I paid for the news letters to see their other picks and follow. I almost lost my shirt on the expensive news letters picks.

I can tell you that stansberry and agora will refund your money if you call them and ask them to before the deadline is up, I even paid $5,000 on one of agoras news letter the financial reserve which was pretty good but not worth 5K,

Stansberry is a big joke, they hype everything up in their teasers and also flood you with even more teaser to entice you to buy more of their services and to tell you the truth none of their picks are much good, they flood you with so much picks that their bound to have a few great ones, but with all the losers it does you no good!!

Agoras outstanding Investments is only $50 a yr and they saved my portfolio. I would of had way more money if I would of just stuck with only their picks.

I would like to find a good micro cap news letter though if anybody knows of one? Most of my money is tied up with Agoras O.I. but I've have some set aside for small caps.

Stansberry new teaser is for "US 810k's" $25 can potentially turn into big profits by reinvesting dividends. Anyone check this out???

The two Jeff Clark publications are quite good. Short Report has had some great options picks this year.

Your welcome blueman , and that was my experience, So it doesn't mean that Stansberry isn't good, It just wasnt good for me at the time I was following it, for about a year.. also Outstanding investment's is mostly long term stocks, but they sure called it right back in late 90's and early part of this decade with all their gold and natural resource picks, like CDE at $1.31 back in 2002 and we sold recently for $5 in 2007, or VLO in 2003 at $10.12 and we are still holding at over $74.00 we got sumcor energy ( SU ) bought at $12.69 back in 2001 and still holding at over $91.00 this is just a few, but as you can see their long term and we still are holding allot of stocks and most still have buy recommends even the ones that are up over 500%, So as you can see OSI is buy and hold mostly, that's why ive been bored lately and feel like gambling on small caps with a portion of my money.

You couldn't find OS? just go to www.argorafinancial.com I could give you all their picks if you want just let me know? we had 6 sell's in 2006 +83%, -50%, -27%, -32%, +141% , +1%, we have four holds and 22 buys that are old and new.

here is a list of gain/loss of the 22 that are still buys 10%, 132%, -22%, 531%, 149%, 419%, -10%, 69%, 59%, 30%, 30%, 8%, -4%, 393%, 281%,57%, 43%, 80%, 173%,76%, 15%, 52%, 24%, 35%, 45%, 8%.. The four holds are 59%, 30%, -4%, 15%, .. So you can see that if you put a equal amount of money into each pick you will be way ahead of the game. whoops I wrote the % from a dec 2006 issue but I looked at the may 2007 % + -% and its similar, I just dont feel like re-writing all again lol sorry.

spacell, thanks again, you obviously know your way around these sights, it's good that there are real people (assuming you are) out there willing to share some of their knowledge with us tinkering newbies.
like maxbid I couldn't find orgorafinancial either but came up with agorafinancial if that's the one, I'd like to take a peek at the buys especially after the numbers you posted.
blueman

Thanks for your info, spaceman_11. I recently subscribed to the S&A Penny Newsletter and it has some interesting recommends for the first few months of the year. One of my pals gets the O.I. newsletter and it seems pretty good.
I just joined the forum today and it looks like a great resource.

I am a newby to investing. I subscribe to Stansberry, penny stocks, gold picks and daily wealth and Martin Weiss. I have only been investing for 5 weeks and have Freeman Mc Moran(FCX) which is up 20%. I have about 3 stocks that are down slightly and 11 that are up. So all in all I am pleased. I am so thrilled to have stumbled on Gumshoe. I too was looking for USG form 4 info. and found you through Google. Keep up the good work.

Does anyone have any info on Nutra Cea?(OTB:NTRZ). I have found a couple of different investment recommendations on it.

I am an Alliance member and have mixed feelings about the worth. You can be overwhelmed by advice from so many publications and cannot own all the stocks recommended. i have had very mixed results with Short Report and have more losers than winners. There is much pump and dump after each recommendation and I have never been able to buy at the price the stock has closed at the night before. Waiting some days may help but the early easy speculative money for the active trader is gone. Stansberry is really for the long term investor and on the positive side their coverage of worldwide opportunities is very good but their research is not always foolproof. I have found their customer service totally lacking in a reasonable response. You ask a question and receive a response based upon some faceless persons interpretation of your question. I asked when they issued a sell on GM as I am still down thousands and they responded 'we are not able to give advice.' It was a big loser for them and the response was no response!!

Ps NTRZ closed at $2.98 Friday. The ship came in..............all aboard! or if your worried "all ashore whose going ashore". Regards.

Very good points Gumshoe

I don't think it would do anybody any good if I posted all of outstanding investment picks here, allot of them have current buys on them still, even the ones up 100% or 500% over the past several. having the symbols only, wouldn't tell you much, it would be better to see the entry date price when they were first recommended, and read about everything they wrote about.

also outstanding investments has been very good to me over the years and its only a $49.00 yr news letter so any body could afford that, and gumshoe is right it wouldn't be fare to the news letters.I try to be a fare person in life also. it's the only NL I subscribe to at the moment.

there's plenty of teasers out there and plenty of us here at the gumshoe to sleuth them out in a honorable fashion to keep us knee deep in stock picks, so no need to post a $49 NL. portfolio.

spaceII I went to AgoraFinancial.com. Looks like good site. They have alot of offers. Can you tell me which specifically is the $49.00 service you have been subscribing to for the past several years with all the great picks you mentioned. They have one service for $99.00 called the Free Market Investor, is that it??? and another Hotline Options service for $995.00! Thanks for your help and reply. Lago748.

I agree with space11 that if a service is a moderate price and has decent picks, then they deserve the money and people should subscribe on their own. Gumshoe, I believe, was started because of those services that want thousands of dollars a year in subscriptions and send out 'teasers' for secret stocks that will turn 10k into a million in 6 months .. guaranteed. I used to decode those on my own and have no problem with a forum like this where we can pool our efforts to decode these teasers. IMO if I was so good at picking winning stocks that I could ask for 2 or 3k or more per year .. I would occasionally give a freebie, telling people .. play this one and with your profit, subscribe to my service.
That would be proof that the service has something to offer.
Instead the teasers keep coming .. I have decoded many secret stocks, played quite a few and lost on more than I have gained .. just a couple of them turned into real winners. For the most part, they seem to be simply hype... but I keep de-coding just in case one day there will be a new little TASR or HANS or VLO or similar among them.
I pay for subscriptions to Breakaway investor and Green Chip Stocks .. GCS has been just OK and Breakaway I am just trying for $49 a year, so far not impressed with their picks. I think I will try the Outstanding Investments one as space seems to have had good luck with that one.
I don't mind services up to $200 a year .. but above that .. it had better be something special for swing trading profits, not buy and hold for 5 years!
My favorite service to date is Robert Hsiu's China Profit Strategy (http://www.chinaprofitstrategy.com) for $199 a year, but this guy is delivering the goods .. and China will be hot, hot for the forseeable future....
(Just be sure to wait for pullbacks before joining existing picks .. the China market is volatile and stocks can lose 10% overnight .. but if you enter right, the rewards are there!)
What I am doing is waiting for major pullbacks, then buying the options ... nice.

Just joined this forum though have been following Stock Gumshoe's teaser blog for a while. Great stuff... Very interesting information - was thinking of signing up for a couple of newsletters and you' all have made the research a bit easier... Hope to contribute a bit .

Second that on China TradeStar - gotta stomach the volatility .

hi all:
any Alliance members out there, who know what Matt Badiali talks about
in his Vancouver mining speculators teaser.

many thanks.

C.R.D

Only one thing needs to be said about Porter Stansberry:

http://www.sec.gov/litigation/complaints/comp18090.htm

'nuff said.

I subscribed to their penny stock letter this year. Glad I've only watched most of the picks and not invested in them. Buyer beware on this one. First off, the "penny" stocks they mention are typically beaten down well known companies that trade between 3 and 10 bucks a share.

Of course in their promotion for this letter, they mention examples of a few stocks that went from trading at a few cents a share to gains in the thousands. Given this sort of hype, I was expecting to see similar kinds of stocks touted in the newsletter.

Last month's recommendation was particularly lame...a closed end US stock equity fund that's been around for years and run by Gabelli inc...not exactly creative when there are hundreds upon hundreds of microcap companies out there. I'm certainly not going to renew, given that the letter's false labeling as a penny stock newsletter.

I lost money and dropped him. Wish I had taken notes as I left with the
impression that he is less than honest in his description of his past performance.

OOPS Let me try this again.

This is their 2007 Report Card
Their
Grade

S&A Short report/ Clark 14.1% A
True Wealth/Sjuggerud 12.2% A
S&A Oil Report/Badiali 10.8% A
Medical Investor/Fannon 8.9% A
Quant Trader/Davis 2.5% B
PSIA/Stansberry 0.0% A
S&A Prospector/Badiali -1.2% C
12% Letter/Dyson -6.5% C
Inside Strategist/Summers -6.6% D
Dividend Grabber/Goldsmith -10.3% F
Sjug.Confidential/Sjuggerud -14.3% F
Phase 1/Fannon -23.1% F
Extreme Value/Ferris -23.4% F
Penny Letter/Ferris -33.5% F
S&A 16 ModelStansberry/Hunt 3.5% C+

These are (Simple averages only) that they report of the 2007 picks.

I'm Sooo tempted to add my opinions here but I'll let you decide for yourselves. Have at it.

http://www.investorvillage.com/smbd.asp?mb=1933&mn=3537&pt=msg&mid=3974554

Re: How to cure HIV 4. From hook to target/[proof of concept

I'm a fundamentals investor. I look for stories that I think will be game changing. Each and every one of SGMO's trials pretty much blows me away. Their VEGF story if the only one out there that induces all isoforms of VEGF. I think their AIDS platform is pretty much the only story out there that can be an actual cure. If Sigma does it right they could have THE complete restriction endonuclease system for modifying genes in eukaryotic cells.

Each of these alone in my head are about a billion dollar valuation several years out. I give their chances for success a broad range %25 - 75%.

I hope SGMO partners with someone like Codon Devices to produce custom synthesized plasmids in a GMP facility.

the down sides is we can expect lots of dilution in the future, most likely starting about 6 months from now and again six months later (after the first phase 2 data sets come out) because 80 million in the bank is not nearly enough to cover all the trials they have coming up even though I really like their burn rate. Sigma and DOW and royalties, as well as royalties from Amgen, Wyeth etc for protein production will stem the dilution somewhat. I just hope SGMO doesnt try to go.

adenylyl

27 reasons to own SGMO 17-Jan-08 08:57 am Zinc fingers are a disruptive technology with a host of applications in medicine and biotechnology, including gene therapy, stem cell modification, protein production and plant breeding.

Savvy business management with deals and alliances that include DOW, Sigma Aldrich and Genentech.

A rapidly developing pipeline that includes angiogenesis, neural regeneration and an entirely novel approach to cure AIDS

Sound science published in top journals and a scientific advisory board that includes a Nobel laureate.

They control the intellectual property rights.

They acquired their sole competitor.

Targeting DNA ‘provokes biological outcomes not achievable at the RNA or protein level’ – offering an entirely new way to treat disease.

ZFP technology is applicable to previously ‘undruggable’ disease targets

Medical breakthroughs will come from combining ZFP technology with stem cells and gene therapy

Promising results for SB509 can be applied in multiple indications (including DN, PAD, ALS and SCI).

SB-509 could become the first disease-modifying drug marketed for diabetic neuropathy.

Type 2 diabetes mellitus is one of the fastest-growing diseases among Western cultures.

The market for DN alone is in excess of $1 billion per annum.

The market for a pain repressor is $750 per annum

New product candidates can be developed in weeks.

Recent results in stem cells promise widespread dissemination of the technology and royalties from Sigma Aldrich.

Sigma Aldrich royalties could exceed $100 million per annum.

Agricultural biotechnology is poised for explosive development

DOW milestones are being met ahead of time, with a deal in the making.

Monetizing the technology in agriculture and biotechnology offsets the costs of clinical development

SGMO's non-transgenic approach could allow crops grown with its products to avoid the genetically modified organism (GMO) designation

Dow royalties could add up to $100 million per annum.

ZFP-enhanced pharmaceutical protein production offers multiple licensing opportunities in a $32 billion market.

Increasing visibility on Wall Street, and accumulation by major institutions.

$80 million in the bank with no warrants and no debts.

Undervalued relative to RNAi, with greater capabilities, including gene activation and correction. (A valuation comparable to SRNA would put the stock at over $25 per share).

Product-enabling platform technologies are limited in their availability. Technology supply-demand favors Sangamo.

I signed up for the 12% letter in December because I liked the essays written by Tom Dyson and he is also the one that got me to buy Realty Income (O). Having read every newsletter he's put out for the last 3 years, on which he's been editor for the last 2, I have to say I am impressed by his approach to income investing which is sometimes unconventional. When I read the S&A year in review my jaw dropped. They pulled no punches in evaluating thier newsletter performance. I have to admit to be impressed by that.

The post by Amyers14 with the sec.gov/litigation/complaints link explained a lot! I had subscribed to one of those letters only to be flooded with offers from the others. I bit for the Agora Reserve at $6497 for life long membership plus a yearly fee, thinking I would get useful information and no longer get their come-ons. Not so. When I did a review of the results they do publish and annualized those "multipliers" the results are not something in which I want to put my trust. And sense I am at the bottom of the learning curve, trust is the correct word! I should have checked here first! We will see if they refund as advertised. I will keep the Outstanding Investments as it seems to be the only long term profitable letter in the group, though not as specific as I need.

For those of you who are bored with steady longterm gains, Option Hotline is fast action. I have lost all the little pot I set aside to try it. Seems like those high "could have sold at" prices only happen for short periods, sometimes under 5 minuets. So unless you stay glued to the monitor market opening to market closing you will miss the best sell point, but it will be reported in the next update.

When I look at my account the green across the board is almost all from one or another of the Motley Fools' recommendations. And some of the dark red! (It is not their fault I had the money to buy BIDU two days before it went down 35%! I should have looked at that recent steep climb up and been smart enough to wait. Hopefully I'm learning!) But the score cards report it all and at a buy in price available to the general public.

Someone mentioned Hulbert Financial Digest. That and this site are two of the best resources I have found for direction toward reliable recommendations. Thank you OneGuy!

May we all learn together! ImL